Raspberries
OtherRed raspberry smoothies drink
NCT Number: NCT04306406
Red raspberries (Rubus idaeus) are a good source of health enhancing hydrolyzable and condensed tannins, flavonoids, anthocyanins, phenolic acids, rheosmin, potassium, carotenoids, vitamin C, and vitamin K1. Compared to other berries commonly consumed in the US, the health benefits of red raspberries to improve pre-diabetes mellitus (PDM) and type 2 diabetes have never been explored. The clinical study proposed in this project seeks to investigate the protective effect of whole red raspberries against insulin resistance, oxidative stress, and inflammation in PDM and type 2 diabetic patients. The in vitro study proposed in the project will assist in identifying the molecular mechanisms by which whole red raspberry protect islet cells against oxidative stress, insulin resistance and loss of cell function.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Red raspberry smoothies drink
Time frame: 2 weeks
Ratio of fasting insulin and glucose
Time frame: 2 weeks
Measure of systemic inflammation
Time frame: 2 weeks
Measure of systemic inflammation
Pennington Biomedical Research Center
Other
Molecular Mechanisms Underlying the Protective Effects of Whole Red Raspberries Against Insulin Resistance and Inflammation in Type 2 Diabetes
Acronym: RASPBERRY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07486557
Body Weight, Central Obesity
Beijing, Beijing Municipality, China
View Trial DetailsNCT07241741
Body Weight, C-reactive Protein
View Trial DetailsNCT05295719
Body Weight, Dyslipidemias
Lubbock, Texas, United States
View Trial DetailsNCT05017571
Body Weight, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial Details